Skip to content

Zolpidem

Ambien, Edluar, Intermezzo, Tovalt Odt, Zolpimist (zolpidem) is a small molecule pharmaceutical. Zolpidem was first approved as Ambien on 1992-12-16. It is used to treat sleep initiation and maintenance disorders in the USA. The pharmaceutical is active against gamma-aminobutyric acid receptor subunit alpha-1. In addition, it is known to target gamma-aminobutyric acid receptor subunit alpha-2 and gamma-aminobutyric acid receptor subunit alpha-3. Ambien's patents are valid until 2032-08-07 (FDA).
Trade Name Ambien, Edluar, Intermezzo, Tovalt Odt, Zolpimist
Common Name Zolpidem
Indication sleep initiation and maintenance disorders
Drug Class Hypnotics/sedatives (zolpidem type)
Zolpidem
Get full access now